| Literature DB >> 35209002 |
Mario Olivieri1, Gianluca Spiteri1, Jessica Brandi2, Daniela Cecconi2, Marina Fusi2, Giovanna Zanoni3, Corrado Rizzi2.
Abstract
Wheat allergens are responsible for symptoms in 60-70% of bakers with work-related allergy, and knowledge, at the molecular level, of this disorder is progressively accumulating. The aim of the present study is to investigate the panel of wheat IgE positivity in allergic Italian bakers, evaluating a possible contribution of novel wheat allergens included in the water/salt soluble fraction. The water/salt-soluble wheat flour proteins from the Italian wheat cultivar Bolero were separated by using 1-DE and 2-DE gel electrophoresis. IgE-binding proteins were detected using the pooled sera of 26 wheat allergic bakers by immunoblotting and directly recognized in Coomassie stained gel. After a preparative electrophoretic step, two enriched fractions were furtherly separated in 2-DE allowing for detection, by Coomassie, of three different proteins in the range of 21-27 kDa that were recognized by the pooled baker's IgE. Recovered spots were analyzed by nanoHPLC Chip tandem mass spectrometry (MS/MS). The immunodetected spots in 2D were subjected to mass spectrometry (MS) analysis identifying two new allergenic proteins: a glucose/ribitol dehydrogenase and a 16.9 kDa class I heat shock protein 1. Mass spectrometer testing of flour proteins of the wheat cultivars utilized by allergic bakers improves the identification of until now unknown occupational wheat allergens.Entities:
Keywords: GRDH; HSP 16.9; baker’s asthma and rhinitis; mass spectrometry; proteomics
Mesh:
Substances:
Year: 2022 PMID: 35209002 PMCID: PMC8875590 DOI: 10.3390/molecules27041212
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Biochemical activities and route of exposure of wheat allergens.
| Allergen | Biochemical Activity | Exposure | Ref. |
|---|---|---|---|
| Ethylene-responsive transcription factor | Plant transcription factor | Inhalation | [ |
| Transcription elongation factor 1 | Plant transcription factor | Inhalation | [ |
| Transcription factor with zinc finger domain | Plant transcription factor | Inhalation | [ |
| Translation factor 5a2 | Translation factor | Inhalation | [ |
| Tri a 15 | Monomeric alpha-amylase inhibitor 0.28 | Inhalation | [ |
| Tri a 29 | Tetrameric alpha-amylase inhibitor CM1/CM2 | Inhalation | [ |
| Tri a 30 | Tetrameric alpha-amylase inhibitor CM3 | Inhalation | [ |
| Tri a 31 | Triosephosphate-isomerase | Inhalation | [ |
| Tri a 32 | 1-cys-peroxiredoxin | Inhalation | [ |
| Tri a 33 | Serpin | Inhalation | [ |
| Tri a 34 | Glyceraldehyde-3-phosphate-dehydrogenase | Inhalation | [ |
| Tri a 35 | Dehydrin | Inhalation | [ |
| Tri a 39 | Serine protease inhibitor-like protein | Inhalation | [ |
| Tri a 40 | Chloroform/methanol-soluble (CM) 17 protein [alpha-amylase inhibitor] | Inhalation | [ |
| 26 kDa endochitinase | Endochitinase | Ingestion | [ |
| b-glucosidase | Glucosidase | Ingestion | [ |
| Class II chitinase | Chitinase | Ingestion | [ |
| Endogenous amylase/subtilisin inhibitor | Alpha amylase/subtilisin inhibitor | Ingestion | [ |
| TLP | Thaumatin like protein | Ingestion | [ |
| Tri a 12 | Profilin | Ingestion | [ |
| Tri a 14 | Non-specific lipid transfer protein 1 | Ingestion | [ |
| Tri a 17 | beta-amylase | Ingestion | [ |
| Tri a 18 | Agglutinin isolectin 1 | Ingestion | [ |
| Tri a 19 | Omega-5 gliadin, seed storage protein | Ingestion | [ |
| Tri a 20 | Gamma gliadin | Ingestion | [ |
| Tri a 21 | Alpha-beta-gliadin | Ingestion | [ |
| Tri a 25 | Thioredoxin | Ingestion | [ |
| Tri a 26 | High molecular weight glutenin | Ingestion | [ |
| Tri a 27 | Thiol reductase homologue | Ingestion | [ |
| Tri a 28 | Dimeric alpha-amylase inhibitor 0.19 | Ingestion | [ |
| Tri a 36 | Prolamin. Low molecular weight glutenin GluB3-23 | Ingestion | [ |
| Tri a 36 | Low molecular weight glutenin GluB3-23 | Ingestion | [ |
| Tri a 37 | a-purothionin. PR-13 family | Ingestion | [ |
| Tri a 41 | Mitochondrial ubiquitin ligase activator of NFKB 1 | Ingestion | [ |
| Tri a 42 | Hypothetical protein from cDNA | Ingestion | [ |
| Tri a 43 | Hypothetical protein from cDNA | Ingestion | [ |
| Tri a 44 | Endosperm transfer cell specific PR60 precursor | Ingestion | [ |
| Tri a 45 | Elongation factor 1 (EIF1) | Ingestion | [ |
| Trypsin/a-amylase inhibitor (AAI) CMX1/CMX3 | Tripsin/a-amylase inhibitor | Ingestion | [ |
| Xylanase inhibitor protein-1 | Xylanase inhibitor | Ingestion | [ |
Demographic and clinical characteristics of work-related wheat allergic bakers and controls.
| Patient | Age (Years) | Sex | Smoking | BMI | FEV1 (%) | FEV1/FVC (%) | PD 20 FEV1 (mcg) | Atopy | WHEAT SPT | Wheat IgE (kU/l) | Total IgE (kU/l) | WRS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 54 | M | N | 32.7 | 91 | 91 | 1074 | Y | + | 11.0 | 2408 | WRR |
| 2 | 39 | M | N | 23.9 | 95 | 108 | >2000 | Y | - | 3.6 | 123 | WRR |
| 3 | 45 | M | Y | 28.9 | 118 | 105 | >2000 | Y | + | 0.6 | 252 | WRR |
| 4 | 34 | M | N | 20.6 | 96 | 108 | >2000 | Y | + | 5.0 | 289 | WRR |
| 5 | 42 | F | N | 19.7 | 84 | 93 | 500 | Y | − | 2.7 | 260 | WRR |
| 6 | 34 | F | N | 21.4 | 104 | 98 | >2000 | Y | − | 0.6 | 49.3 | WRR |
| 7 | 33 | M | N | 21.1 | 100 | 104 | >2000 | Y | − | 22.8 | 1098 | WRR |
| 8 | 33 | M | N | 23.9 | 105 | 97 | >2000 | Y | + | 0.4 | 74.4 | WRR |
| 9 | 37 | M | Y | 26.0 | 93 | 93 | 30 | Y | + | 3.0 | 104 | WRR |
| 10 | 39 | M | N | 29.8 | 113 | 99 | 1939 | N | + | 15.8 | 208 | WRR |
| 11 | 32 | M | Y | 29.0 | 103 | 96 | >2000 | N | + | 8.9 | 138 | WRR |
| 12 | 58 | M | N | 30.9 | 118 | 104 | 63 | Y | + | 17.6 | 885 | WRAS |
| 13 | 53 | M | N | 38.2 | 108 | 104 | 76 | Y | + | 38.5 | 407 | WRAS |
| 14 | 46 | M | N | 23.2 | 112 | 106 | >2000 | N | + | 9.7 | 44.9 | WRAS |
| 15 | 50 | M | N | 26.2 | 122 | 109 | >2000 | Y | + | 3.6 | 318 | WRAS |
| 16 | 40 | M | N | 28.7 | 100 | 87 | ND | N | − | 0.9 | 63 | WRAS |
| 17 | 35 | M | N | 23.9 | 105 | 97 | >2000 | Y | + | 3.3 | 106 | WRAS |
| 18 | 55 | M | N | 22.1 | 59 | 96 | ND | Y | + | 46.9 | 817 | WRAS, WRR |
| 19 | 29 | F | N | 24.8 | 98 | 93 | 21 | Y | + | 47.2 | 1383 | WRAS, WRR |
| 20 | 33 | M | N | 49.1 | 90 | 84 | ND | N | − | 0.4 | 216 | WRAS, WRR |
| 21 | 69 | M | N | 26.0 | 97 | 98 | >2000 | Y | + | 7.3 | 213 | WRAS, WRR |
| 22 | 37 | M | N | 30.9 | 75 | 87 | ND | Y | + | 937.0 | 8291 | WRAS, WRR |
| 23 | 35 | M | Y | 29.0 | 103 | 96 | 438 | Y | + | 40.8 | 1038 | WRAS, WRR |
| 24 | 54 | M | N | 25.0 | 110 | 86 | ND | N | + | 24.4 | 1163 | WRAS, WRR |
| 25 | 28 | F | Y | 33.5 | 118 | 115 | 68 | Y | + | 28.8 | 547 | WRAS, WRR |
| 26 | 68 | M | N | 33.3 | 83 | 83 | ND | Y | + | 407 | 1594 | WRAS, WRR |
| C1 | 26 | F | N | 23.2 | 112 | 106 | >2000 | N | − | <0.35 | 39.9 | − |
| C2 | 28 | F | Y | 22.3 | 113 | 123 | >2000 | N | − | <0.35 | <2 | − |
WRS: Work-Related Symptoms; WRAS: Work-Related Asthma Symptoms; WRR: Work-Related Rhinitis; Y: Yes; N: No; ND: Not Done; + and −: positive negative SPT; C1 and C2: controls.
Figure 1WSSP resolved by SDS-PAGE and probed with the single sera of the bakers with work-related symptoms: rhinitis only (panel (A), lanes 1–11), asthma only (panel (B), lanes 12–17), asthma and rhinitis (panel (C), lanes 18–26) and controls (lane C1 and C2).
Figure 2WSSP stained by Coomassie blue 2-DE (panel (A)) and immunodetected by IgE-Blotting with the pooled sera of bakers with work-related symptoms (panel (B)). The arrows of panel B indicate the spots identified by nanoHPLC-Chip-tandem MS/MS. Spot highlighted by arrow 1 was identified as a monomeric alpha amylase inhibitor, while spot indicated by arrow 2 as a glucose/ribitol dehydrogenase. Further spots with MW in the range of about 21–27 kDa are well visualized by IgE blotting (panel (B)) but not stained by Coomassie in 2-DE.
Figure 3Panel (A): 16% SDS-PAGE, Lane 1: MW markers; lane 2: total WSSP, lanes from 3 to 15: fractionated WSSP by electroendosmotic preparative gel electrophoresis. The arrows indicate the fractions resolved by 2-DE and IgE-Blotting (panel (B,C) respectively). Arrow (3) in panel (B) indicates the spot identified as 16.9 kDa class I heat shock protein 1, while the two arrows in panel (C) indicate the spots identified as triosephosphate isomerase (4) and thioredoxin peroxidase (5), respectively.
List of identified proteins by nanoHPLC Chip tandem mass spectrometry (MS/MS).
| ID | Protein | Uniprot Accession ID | MW * | pI ** | Protein Sequence Coverage | MASCOT Score |
|---|---|---|---|---|---|---|
| 1 | Alpha-amylase inhibitor 0.28 | IAA2_WHEAT | 16788 | 7.45 | 22 | 59 |
| 2 | Glucose/ribitol dehydrogenase homolog | GRDH_ORYSJ | 32247 | 5.76 | 7 | 71 |
| 3 | 16.9 kDa class I heat shock protein 1 | HS16A_WHEAT | 16868 | 5.83 | 37 | 106 |
| 4 | Triosephosphate isomerase, cytosolic | TPIS_HORVU | 26720 | 5.39 | 18 | 167 |
| 5 | 1-Cys peroxiredoxin PER1 | REHY_WHEAT | 23950 | 6.08 | 23 | 116 |
* MW: theoretical molecular weight; ** pI: theoretical isoelectric point.